|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/20 | |
| A61K 31/437 |
| (11) | Patento numeris | 3416627 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18718476.7 |
| Europos patento paraiškos padavimo data | 2018-04-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2018/060547 |
| Data | 2018-04-25 |
| (87) | Numeris | WO 2018/197538 |
| Data | 2018-11-01 |
| (30) | Numeris | Data | Šalis |
| 17168281 | 2017-04-26 | EP |
| (72) |
SCHWARZ, Franz Xaver, AT
|
| (73) |
Sandoz AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA |
| ORAL DOSAGE FORM COMPRISING RIFAXIMIN IN FORM BETA |